Literature DB >> 19844812

Involvement of Fc receptors in disorders of the central nervous system.

Eitan Okun1, Mark P Mattson, Thiruma V Arumugam.   

Abstract

Immunoglobulins are proteins with a highly variable antigen-binding domain and a constant region (Fc domain) that binds to a cell surface receptor (FcR). Activation of FcRs in immune cells (lymphocytes, macrophages, and mast cells) triggers effector responses including cytokine production, phagocytosis, and degranulation. In addition to their roles in normal responses to infection or tissue injury, and in immune-related diseases, FcRs are increasingly recognized for their involvement in neurological disorders. One or more FcRs are expressed in microglia, astrocytes, oligodendrocytes, and neurons. Aberrant activation of FcRs in such neural cells may contribute to the pathogenesis of major neurodegenerative conditions including Alzheimer's disease, Parkinson's disease, ischemic stroke, and multiple sclerosis. On the other hand, FcRs may play beneficial roles in counteracting pathological processes; for e.g., FcRs may facilitate removal of amyloid peptides from the brain and so protect against Alzheimer's disease. Knowledge of the functions of FcRs in the nervous system in health and disease is leading to novel preventative and therapeutic strategies for stroke, Alzheimer's disease, and other neurological disorders.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19844812      PMCID: PMC2878892          DOI: 10.1007/s12017-009-8099-5

Source DB:  PubMed          Journal:  Neuromolecular Med        ISSN: 1535-1084            Impact factor:   3.843


  162 in total

1.  Increased expression of transferrin receptors and iron in amoeboid microglial cells in postnatal rats following an exposure to hypoxia.

Authors:  C Kaur; E A Ling
Journal:  Neurosci Lett       Date:  1999-03-12       Impact factor: 3.046

2.  FcepsilonRII/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells.

Authors:  S Hunot; N Dugas; B Faucheux; A Hartmann; M Tardieu; P Debré; Y Agid; B Dugas; E C Hirsch
Journal:  J Neurosci       Date:  1999-05-01       Impact factor: 6.167

3.  CD40/CD40 ligand signaling in mouse cerebral microvasculature after focal ischemia/reperfusion.

Authors:  Mami Ishikawa; Thorsten Vowinkel; Karen Y Stokes; Thiruma V Arumugam; Gokhan Yilmaz; Anil Nanda; D Neil Granger
Journal:  Circulation       Date:  2005-03-28       Impact factor: 29.690

Review 4.  IgA: an immune glycoprotein.

Authors:  Esther M Yoo; Sherie L Morrison
Journal:  Clin Immunol       Date:  2005-07       Impact factor: 3.969

5.  Low affinity Fc gamma receptors on murine macrophages: mitogen-activated protein kinase activation and AP-1 DNA binding activity.

Authors:  M J Cote-Vélez; E Ortega; A Ortega
Journal:  Immunol Lett       Date:  1999-04-15       Impact factor: 3.685

Review 6.  Stroke and T-cells.

Authors:  Thiruma V Arumugam; D Neil Granger; Mark P Mattson
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

7.  Role of Src in the modulation of multiple adaptor proteins in FcalphaRI oxidant signaling.

Authors:  R K Park; K D Izadi; Y M Deo; D L Durden
Journal:  Blood       Date:  1999-09-15       Impact factor: 22.113

8.  Effects of cerebrospinal fluid from patients with Parkinson disease on dopaminergic cells.

Authors:  W D Le; D B Rowe; J Jankovic; W Xie; S H Appel
Journal:  Arch Neurol       Date:  1999-02

9.  FcgammaRIV: a novel FcR with distinct IgG subclass specificity.

Authors:  Falk Nimmerjahn; Pierre Bruhns; Ken Horiuchi; Jeffrey V Ravetch
Journal:  Immunity       Date:  2005-07       Impact factor: 31.745

Review 10.  Oxidative stress in brain ischemia.

Authors:  S Love
Journal:  Brain Pathol       Date:  1999-01       Impact factor: 6.508

View more
  56 in total

1.  Anti-streptococcus IgM antibodies induce repetitive stereotyped movements: cell activation and co-localization with Fcα/μ receptors in the striatum and motor cortex.

Authors:  Danhui Zhang; Ankur Patel; Youhua Zhu; Allan Siegel; Steven S Zalcman
Journal:  Brain Behav Immun       Date:  2012-01-21       Impact factor: 7.217

Review 2.  Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature.

Authors:  Tony Wyss-Coray; Joseph Rogers
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

3.  Two novel Tau antibodies targeting the 396/404 region are primarily taken up by neurons and reduce Tau protein pathology.

Authors:  Jiaping Gu; Erin E Congdon; Einar M Sigurdsson
Journal:  J Biol Chem       Date:  2013-10-02       Impact factor: 5.157

4.  Effects of Low Phytanic Acid-Concentrated DHA on Activated Microglial Cells: Comparison with a Standard Phytanic Acid-Concentrated DHA.

Authors:  María Belén Ruiz-Roso; Elena Olivares-Álvaro; José Carlos Quintela; Sandra Ballesteros; Juan F Espinosa-Parrilla; Baltasar Ruiz-Roso; Vicente Lahera; Natalia de Las Heras; Beatriz Martín-Fernández
Journal:  Neuromolecular Med       Date:  2018-05-30       Impact factor: 3.843

5.  Probing the extracellular diffusion of antibodies in brain using in vivo integrative optical imaging and ex vivo fluorescence imaging.

Authors:  Daniel J Wolak; Michelle E Pizzo; Robert G Thorne
Journal:  J Control Release       Date:  2014-11-07       Impact factor: 9.776

6.  Autoantibody-induced internalization of CNS AQP4 water channel and EAAT2 glutamate transporter requires astrocytic Fc receptor.

Authors:  Shannon R Hinson; Ian C Clift; Ningling Luo; Thomas J Kryzer; Vanda A Lennon
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-01       Impact factor: 11.205

7.  Immunoglobulin genotypes and cognitive functions in schizophrenia.

Authors:  Janardan P Pandey; Aryan M Namboodiri; Paul J Nietert; Reiji Yoshimura; Hikaru Hori
Journal:  Immunogenetics       Date:  2017-09-22       Impact factor: 2.846

8.  IgG4 can induce an M2-like phenotype in human monocyte-derived macrophages through FcγRI.

Authors:  Jennifer F A Swisher; Devin A Haddad; Anna G McGrath; Gunther H Boekhoudt; Gerald M Feldman
Journal:  MAbs       Date:  2014       Impact factor: 5.857

9.  Admixture of beneficial and unfavourable variants of GLCCI1 and FCER2 in Roma samples can implicate different clinical response to corticosteroids.

Authors:  Renata Szalai; Petra Matyas; Dalma Varszegi; Marton Melegh; Lili Magyari; Luca Jaromi; Katalin Sumegi; Balazs Duga; Erzsebet Kovesdi; Kinga Hadzsiev; Bela Melegh
Journal:  Mol Biol Rep       Date:  2014-08-05       Impact factor: 2.316

10.  Mast cell isolation from the immature rat brain.

Authors:  Shyama D Patel; Gillian Brennan; Jacqueline Brazin; Amber J Ciardiello; Randi B Silver; Susan J Vannucci
Journal:  Dev Neurosci       Date:  2013-05-25       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.